PMEF
IMGN

Point72 Middle East FZE’s Immunogen Inc IMGN Stock Holding History

Point72 Middle East FZE’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-31,665
Closed -$939K – 1440
2023
Q4 		$939K Buy
+31,665
New +$631K 0.03% 636

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $11.5B AUM 18.82% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Point72 Middle East FZE's IMGN Position: Q1 2024 in Review

Point72 Middle East FZE sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 31,665 shares — an estimated $939K sold.

Point72 Middle East FZE first reported a position in IMGN in Q4 2023 and held it in 1 quarter. The position peaked at $939K in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Point72 Middle East FZE reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Point72 Middle East FZE sold 31,665 Immunogen Inc shares in Q1 2024, an estimated $939K.
  • Point72 Middle East FZE first reported a position in Immunogen Inc in Q4 2023 and held it in 1 quarter.
  • Point72 Middle East FZE's Immunogen Inc position peaked at $939K in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Point72 Middle East FZE's 13F filing for Q1 2024.